top of page
Browse by category
Search


Roche and Zealand Pharma to co-develop and co-commercialise petrelintide for metabolic diseases
Roche and Zealand Pharma have entered into an exclusive collaboration and licensing agreement to co-develop and co-commercialise...


Zealand Pharma enrols 1st patient in ZUPREME-1 trial of petrelintide
Zealand Pharma has enrolled the first participant has been enrolled in ZUPREME-1, a global Phase 2b trial in people with obesity or...
Browse by tag





bottom of page